Chambers Review
Provided by Chambers
Europe
Capital Markets: Equity - France
Individual Editorial
Guilhem Richard joins the rankings this year after praise for his experience on IPOs and capital increases. He joined Goodwin in September 2024.
Email address
[email protected]Contact number
+33 (0)1 85 65 72 71Share profile
Up and Coming
Provided by Guilhem Richard
Guilhem Richard is a partner in Goodwin’s Life Sciences and Technology groups.
He specializes in capital markets and corporate finance particularly in the biotech, medtech and tech sectors. His experience includes a wide range of capital market transactions on Euronext and Nasdaq from equity (IPOs, dual listings, capital increases, private placements, block sales and ATM offerings…) to debt (high yield, OCEANE, ORA).
Guilhem also assists listed companies and their boards with their financing strategies and day-to-day issues relating to corporate and securities law and corporate governance.
Prior to joining Goodwin, Guilhem was a partner at Gide and previously worked in other international law firms.
Master, University of Paris I – Panthéon-Sorbonne (Business Law); Master, Université Catholique de Louvain (Economic Law); Master, ESCP Business School (Management)
Provided by Chambers
Guilhem Richard joins the rankings this year after praise for his experience on IPOs and capital increases. He joined Goodwin in September 2024.
Provided by Chambers
"Guilhem has a particular expertise in cross-border IPOs into the US."
"I strongly value Richard's expertise and views."
"Guilhem has a particular expertise in cross-border IPOs into the US."
"I strongly value Richard's expertise and views."